| Date | Title | Description |
| 06.09.2024 | ArisGlobal and Sitero Expand Strategic Partnership to Enable Best-in-Class Capabilities Across Complete Drug Development Technology Platform | Strategic collaboration strengthens end-to-end connectivity & data flow across the drug development platform, ensuring seamless interoperability across Clinical, Safety, Regulatory, Medical Affairs, and Quality platforms.
BOSTON, Sept. ... |
| 11.07.2024 | Newest Version of LifeSphere® Regulatory Platform Allows Organizations to Leverage Latest GenAI Technology | End-to-end functionality helps cut skyrocketing costs of compliance & removes workflow inefficiencies
The cloud-based platform demonstrates 50%+ efficiency gains across Regulatory Operations by bringing together data, content, and proce... |
| 02.07.2024 | OMNY Health debuts platform to fuel AI in healthtech | The company's first two AI partners are QuantHealth and ArisGlobal
Data is everything in healthcare, but it's especially important when it comes to artificial intelligence: while every company wants to be an AI company, and most of them say... |
| 27.06.2024 | Top 5 Global Biotech Company Goes Live with LifeSphere® MultiVigilance and Reporting & Analytics Solution | The top-tier life sciences company will standardize its Safety operations on the cloud-powered technology platform, LifeSphere, which is propelling life sciences GenAI use cases.
The company will use LifeSphere MultiVigilance and Reporting ... |
| 10.06.2024 | Steve Nuckols Joins ArisGlobal as Chief Customer Officer | Nuckols will apply decades of both life sciences and technology leadership to enhance innovation and customer focus at ArisGlobal
BOSTON, June 10, 2024 /PRNewswire/ -- ArisGlobal, a technology company at the forefront of life sciences and c... |
| 08.05.2024 | New Momentum in Pharma Automation: ArisGlobal's 2024 Industry Survey Report Highlights Surge in AI-Powered Safety & Regulatory Processes | The pace of companies' transitions to intelligent automation is accelerating: 60% are looking to explore new usage or increase their usage of advanced technologies over the next 18 months.
Today, while more than 75% of organizations claim t... |
| 03.05.2024 | ArisGlobal Revolutionizes Safety Signal Processing for Boehringer Ingelheim | LifeSphere Clarity redefines safety signal analysis for pharmaceutical giant Boehringer Ingelheim, setting a new standard in patient safety and risk management.
In the fast-paced world of pharmaceuticals, innovation is key. ArisGlobal, a le... |
| 01.05.2024 | ArisGlobal Helps Boehringer Ingelheim Transform Safety Signal Processing by Leveraging Latest LifeSphere Solutions | LifeSphere Clarity drives efficiencies and reinvents the way Boehringer Ingelheim's pharmaceutical operations approach safety signals
BOSTON, May 1, 2024 /PRNewswire/ -- ArisGlobal, a market leader in Life Sciences technology and the creato... |
| 01.05.2024 | ArisGlobal Helps Boehringer Ingelheim Transform Safety Signal Processing by Leveraging Latest LifeSphere Solutions | LifeSphere Clarity drives efficiencies and reinvents the way Boehringer Ingelheim's pharmaceutical operations approach safety signals
BOSTON, May 1, 2024 /PRNewswire/ -- ArisGlobal, a market leader in Life Sciences technology and the creato... |
| 23.04.2024 | Significant Case Intake Efficiencies Found in Newly Launched Life Sciences Generative AI Solution | Advanced Intake™ demonstrates up to 65% efficiency gains in adverse case intake and 90% data extraction accuracy and quality
BOSTON, April 23, 2024 /PRNewswire/ -- ArisGlobal, an innovative life sciences technology company and creator of Li... |
| 23.04.2024 | Significant Case Intake Efficiencies Found in Newly Launched Life Sciences Generative AI Solution | Advanced Intake™ demonstrates up to 65% efficiency gains in adverse case intake and 90% data extraction accuracy and quality
BOSTON, April 23, 2024 /PRNewswire/ -- ArisGlobal, an innovative life sciences technology company and creator of Li... |
| 05.02.2024 | ArisGlobal Launches GenAI Council for Advance Life Sciences Innovation | Group announces inaugural session as well as its charter — to advance the use of GenAI in life sciences R&D
ArisGlobal, a leading innovative life sciences technology company and creator of LifeSphere, announced the formal charter for th... |
| 15.12.2023 | Expediting R&D Digitization for Life Sciences, ArisGlobal Introduces LifeSphere® NavaX™ – The Next-Generation Cognitive Computing Engine | NavaX will revolutionize the end-to-end Research and Development processes with the latest advanced technologies
ArisGlobal, a market leader in Life Sciences technology and the creator of LifeSphere®, has launched LifeSphere NavaX, a cuttin... |
| 30.06.2023 | Recent Digital Health Hires & Board Appointments | Theralink Technologies, Inc. appoints Faith Zaslavsky as its new Chief Executive Officer. Ms. Zaslavsky, who has served as the Company’s President and Chief Operating Officer since December 2022, will assume this role effective June 26, 202... |
| 29.06.2023 | Best Practices in Pharmacovigilance: Unleash the Power of Artificial Intelligence, Upcoming Webinar Hosted by Xtalks | Touchless case processing, an emerging practice that eliminates the need for manual intervention, is set to bring about next-level efficiency gains in pharmacovigilance.
TORONTO (PRWEB) June 29, 2023
In the life sciences industry, the press... |
| 22.06.2023 | ArisGlobal Enhances Leadership Team with Two C-Suite Appointments and Advances Global Operating Model | Jessel Renolayan, Tech Times 22 June 2023, 11:06 pm
ArisGlobal today announces key evolution of its executive team and global operating model; changes that reflect the growth needs of the leading provider of life sciences SaaS solutions.
(P... |
| 23.05.2023 | 10+ things to know in #MiamiTech: Tech salaries in Miami, plus news about Magic Leap, Brightline, Opportunity Miami, Borderless Capital, INIT, Seaworthy & more | Facebook
Tweet
Pin
LinkedIn
Email
1 Magic Leap, Meta reportedly in talks over potential multiyear partnership
Meta is currently in talks with South Florida-based Magic Leap to strike a multiyear deal that could include intellectual property... |
| 18.05.2023 | ArisGlobal Acquires Leading Regulatory Data Solution SPORIFY | Jessel Renolayan, Tech Times 18 May 2023, 06:05 pm
ArisGlobal, a leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere®, today announces its acquis... |
| 16.05.2023 | ArisGlobal Acquires Sporify | ArisGlobal, a Miami, FL-based provider of life sciences software designed to automate core drug development functions, acquired Sporify, a Dublin, Ireland-based company focused on consistent and ISO IDMP-compliant SPOR data to feed regulato... |
| 04.05.2023 | ArisGlobal Strengthens Leadership Team with Addition of Chief Marketing Officer | Jessel Renolayan, Tech Times 04 May 2023, 09:05 pm
ArisGlobal, the leading provider of life sciences software, today announces the appointment of Julie Springer as its first Chief Marketing Officer (CMO).
"We are thrilled to welcome Ju... |
| 25.04.2023 | Global Product Management: Navigating Regulatory Pressures with Automation & Interconnected Data, Upcoming Webinar Hosted by Xtalks | Life sciences companies can leverage advanced technologies like artificial intelligence (AI) to reduce manual effort and save time by shifting functions like ingestion and tracking of health authority correspondence from mostly manual to au... |
| 01.03.2023 | ArisGlobal to Acquire Amplexor Life Sciences | ‘
ArisGlobal, a Miami, FL-based provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere®, acquired Amplexor Life Sciences (LS), a Novo Mesto, Slovenia-based ... |
| 28.02.2023 | ArisGlobal Signs Agreement to Acquire Amplexor Life Sciences, Creating the Most Comprehensive Regulatory SaaS Platform for the Industry | Jessel Renolayan, Tech Times 28 February 2023, 06:02 pm
ArisGlobal, the leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere® today announces the ... |
| 22.12.2022 | Life Sciences Technology Leader ArisGlobal Releases 2022 Industry Report, Shows Steady and Growing Interest in Intelligent Automation | Jessel Renolayan, Tech Times 22 December 2022, 02:12 am
ArisGlobal, the leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere®, today announces the... |
| 09.09.2022 | ArisGlobal Accelerates Growth, Announces Executive Evolution | Jessel Thomas, Tech Times 09 September 2022, 01:09 am
ArisGlobal, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere®, today announces an expansio... |
| 27.08.2022 | ArisGlobal Heads to Boston for Flagship Life Sciences Conference, Breakthrough 2022 | Jessel Thomas, Tech Times 27 August 2022, 05:08 am
ArisGlobal, the leading provider of life sciences software that automates core drug development with its end-to-end drug development technology platform, LifeSphere®, today announced the le... |
| 23.08.2022 | ArisGlobal’s LifeSphere Regulatory IDMP Product Leader Invited to Chair American National Standards Institute Global MPID Project | Jessel Thomas, Tech Times 23 August 2022, 05:08 am
ArisGlobal, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere®, today recognizes and applauds ... |
| 20.07.2022 | ArisGlobal Announces New Brand Identity for Award-Winning Life Sciences SaaS Platform, LifeSphere | Jessel Thomas, Tech Times 20 July 2022, 12:07 am
ArisGlobal, the leading provider of life sciences software that automates core drug development with its end-to-end technology platform LifeSphere®, has taken the next step in its evolution b... |
| 17.06.2022 | PMI Life Sciences Goes Live with LifeSphere Safety to Modernize Global Safety Surveillance | Jessel Thomas, Tech Times 17 June 2022, 01:06 am
ArisGlobal, the leading provider of life sciences software that automates core research and development processes with its end-to-end technology platform LifeSphere®, today announces that PMI... |
| 07.05.2022 | ArisGlobal Continues Growth With Key Leadership Hires and Expanded Functions | Jessel Thomas, Tech Times 07 May 2022, 10:05 am
ArisGlobal, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere®, today announces corporate develop... |
| 05.04.2022 | ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East | Jessel Thomas, Tech Times 05 April 2022, 11:04 pm
ArisGlobal, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere®, today announces significant gro... |
| 11.02.2022 | 3 Reasons to Implement an IDMP Solution Early | Robin Schilling, Global Project Manager IDMP at ArisGlobal
The European Union (EU) has announced guidance on the Identification of Medicinal Product (IDMP) — and pharmaceutical companies around the world should take notice. While the EU wil... |
| 05.08.2021 | ArisGlobal Lauded by Frost & Sullivan for Enabling Life Sciences Companies to Accelerate R&D with Its LifeSphere® Platform | LifeSphere® ably supports clients by expediting decision-making, maintaining compliance, and streamlining collaborations among cross-functional teams
SANTA CLARA, Calif., Aug. 5, 2021 /PRNewswire/ -- Based on its recent analysis of the Nort... |
| 17.06.2019 | The Hot IPO You Might Have Overlooked: Term Sheet | CONSUMERIZE THE ENTERPRISE
While we all gave our undivided attention to flashy IPOs like Uber and Lyft, many overlooked the public market debut of cloud-based cybersecurity company CrowdStrike. You’ve probably heard of it without realizing ... |
| - | Why PV Signal Teams Must Leverage RWD & Advanced Cognitive Computing | Art Brown, Director of Product Marketing, LifeSphere Clinical, ArisGlobal
Signal detection — one of the most critical activities within pharmacovigilance (PV) — is the process of searching for and identifying safety signals from a variety o... |
